Laura E. Wise

1.9k total citations
34 papers, 1.5k citations indexed

About

Laura E. Wise is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Toxicology. According to data from OpenAlex, Laura E. Wise has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 19 papers in Cellular and Molecular Neuroscience and 8 papers in Toxicology. Recurrent topics in Laura E. Wise's work include Cannabis and Cannabinoid Research (21 papers), Neuroscience and Neuropharmacology Research (12 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). Laura E. Wise is often cited by papers focused on Cannabis and Cannabinoid Research (21 papers), Neuroscience and Neuropharmacology Research (12 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). Laura E. Wise collaborates with scholars based in United States, Türkiye and Denmark. Laura E. Wise's co-authors include Aron H. Lichtman, Benjamin F. Cravatt, Stephen A. Varvel, Andrew Thorpe, Rehab A. Abdullah, Dana E. Selley, Steven G. Kinsey, Pamela E. Knapp, Sudeshna Ghosh and Justin L. Poklis and has published in prestigious journals such as Nature Neuroscience, Biological Psychiatry and Brain Research.

In The Last Decade

Laura E. Wise

34 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura E. Wise United States 23 915 722 357 271 212 34 1.5k
Ellen B. Geller United States 25 379 0.4× 990 1.4× 590 1.7× 127 0.5× 425 2.0× 58 1.8k
Joyonna Gamble‐George United States 14 562 0.6× 511 0.7× 144 0.4× 211 0.8× 114 0.5× 23 1.1k
Rehab A. Abdullah United States 24 1.5k 1.6× 834 1.2× 250 0.7× 315 1.2× 334 1.6× 30 1.7k
M. Ruth Pazos Spain 27 2.4k 2.6× 1.5k 2.0× 426 1.2× 516 1.9× 287 1.4× 49 3.0k
Jean Marchand France 7 1.9k 2.1× 935 1.3× 307 0.9× 402 1.5× 294 1.4× 15 2.1k
Natalia Realini Italy 25 1.6k 1.7× 1.1k 1.6× 582 1.6× 322 1.2× 230 1.1× 43 2.4k
Ewa Kozela Israel 24 1.0k 1.1× 626 0.9× 444 1.2× 212 0.8× 256 1.2× 35 1.7k
Ana Juknat Israel 21 1.3k 1.4× 467 0.6× 298 0.8× 236 0.9× 112 0.5× 23 1.7k
Eileen M. Briley United States 14 1.9k 2.0× 1.3k 1.7× 434 1.2× 348 1.3× 237 1.1× 15 2.6k
Nancy E. Buckley United States 18 2.0k 2.2× 883 1.2× 677 1.9× 484 1.8× 385 1.8× 26 2.7k

Countries citing papers authored by Laura E. Wise

Since Specialization
Citations

This map shows the geographic impact of Laura E. Wise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Wise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Wise more than expected).

Fields of papers citing papers by Laura E. Wise

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Wise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Wise. The network helps show where Laura E. Wise may publish in the future.

Co-authorship network of co-authors of Laura E. Wise

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Wise. A scholar is included among the top collaborators of Laura E. Wise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Wise. Laura E. Wise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grim, Travis W., Bogna M. Ignatowska‐Jankowska, Tao Qing, et al.. (2016). Pharmacological characterization of repeated administration of the first generation abused synthetic cannabinoid CP47,497. Journal of Basic and Clinical Physiology and Pharmacology. 27(3). 217–228. 15 indexed citations
2.
Wilkerson, Jenny L., Micah J. Niphakis, Travis W. Grim, et al.. (2016). The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model. Journal of Pharmacology and Experimental Therapeutics. 357(1). 145–156. 53 indexed citations
3.
Ghosh, Sudeshna, Steven G. Kinsey, Qing-song Liu, et al.. (2015). Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice. Journal of Pharmacology and Experimental Therapeutics. 354(2). 111–120. 39 indexed citations
4.
Hait, Nitai C., Laura E. Wise, Jeremy C. Allegood, et al.. (2014). Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory. Nature Neuroscience. 17(7). 971–980. 166 indexed citations
5.
Kinsey, Steven G., Laura E. Wise, Divya Ramesh, et al.. (2013). Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1–Mediated Antinociceptive and Gastroprotective Effects. Journal of Pharmacology and Experimental Therapeutics. 345(3). 492–501. 127 indexed citations
6.
Wise, Laura E., et al.. (2012). l-theanine attenuates abstinence signs in morphine-dependent rhesus monkeys and elicits anxiolytic-like activity in mice. Pharmacology Biochemistry and Behavior. 103(2). 245–252. 10 indexed citations
7.
Wise, Laura E., Kelly A. Long, Rehab A. Abdullah, et al.. (2012). Dual Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Blockade Produces THC-Like Morris Water Maze Deficits in Mice. ACS Chemical Neuroscience. 3(5). 369–378. 54 indexed citations
8.
Ghosh, Sudeshna, Laura E. Wise, Yugang Chen, et al.. (2012). The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model. Life Sciences. 92(8-9). 498–505. 99 indexed citations
9.
Wise, Laura E., Stephen A. Varvel, Dana E. Selley, et al.. (2011). ∆9-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory. Psychopharmacology. 217(4). 485–494. 15 indexed citations
10.
Wise, Laura E., et al.. (2009). Fatty acid amide hydrolase (FAAH) knockout mice exhibit enhanced acquisition of an aversive, but not of an appetitive, Barnes maze task. Neurobiology of Learning and Memory. 92(4). 597–601. 25 indexed citations
11.
Wise, Laura E., Andrew Thorpe, & Aron H. Lichtman. (2009). Hippocampal CB1 Receptors Mediate the Memory Impairing Effects of Δ9-Tetrahydrocannabinol. Neuropsychopharmacology. 34(9). 2072–2080. 115 indexed citations
12.
Varvel, Stephen A., Laura E. Wise, & Aron H. Lichtman. (2009). Are CB1 receptor antagonists nootropic or cognitive impairing agents?. Drug Development Research. 70(8). 555–565. 13 indexed citations
13.
Wise, Laura E., Philip A. Iredale, & Aron H. Lichtman. (2008). The cannabinoid CB1 receptor antagonist CE prolongs spatial memory duration in a rat delayed radial arm maze memory task. European Journal of Pharmacology. 590(1-3). 246–249. 17 indexed citations
14.
Wise, Laura E., et al.. (2007). Combination of Rimonabant and Donepezil Prolongs Spatial Memory Duration. Neuropsychopharmacology. 32(8). 1805–1812. 43 indexed citations
15.
Wise, Laura E. & Aron H. Lichtman. (2007). The uncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist memantine prolongs spatial memory in a rat delayed radial-arm maze memory task. European Journal of Pharmacology. 575(1-3). 98–102. 36 indexed citations
16.
Wise, Laura E., et al.. (2007). Evaluation of fatty acid amides in the carrageenan-induced paw edema model. Neuropharmacology. 54(1). 181–188. 54 indexed citations
17.
Varvel, Stephen A., et al.. (2006). Inhibition of Fatty-Acid Amide Hydrolase Accelerates Acquisition and Extinction Rates in a Spatial Memory Task. Neuropsychopharmacology. 32(5). 1032–1041. 135 indexed citations
18.
Varvel, Stephen A., et al.. (2004). ?9-THC-induced cognitive deficits in mice are reversed by the GABAA antagonist bicuculline. Psychopharmacology. 178(2-3). 317–327. 34 indexed citations
19.
Varvel, Stephen A., et al.. (2002). Effects of antipsychotic drugs on operant responding after acute and repeated administration. Psychopharmacology. 160(2). 182–191. 30 indexed citations
20.
Porter, Joseph H., et al.. (2000). Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats. Psychopharmacology. 149(2). 189–193. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026